ARNA Intraday Update: Shareholders Exiting (ARNA)
Arena Pharma (NASDAQ: ARNA) last price check is $1.89, down 7.35% after the announcement today; the completion of an end-of-review meeting with the US Food and Drug Administration (FDA) for the lorcaserin New Drug Application.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Food and Drug AdministrationLong Ideas News Short Ideas Trading Ideas